Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.

Saved in:
Bibliographic Details
Title: Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.
Authors: Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.; Department of Medicine, Medical School, Trinity College Dublin University, Dublin, Ireland., Meyer T; Department of Oncology, Royal Free Hospital, London, UK.; Department of Oncology, UCL Cancer Institute, University College London, London, UK., Do RKG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Light JS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sherrin S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yaqubie A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Neill AC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA., Al-Rajabi R; Department of Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Denlinger CS; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Cano P; Department of Hematology/Oncology, Sudbury Regional Hospital, Sudbury, ON, Canada., Cornelius AS; Department of Medicine, Helen DeVos Children's Hospital, Grand Rapids, MI, USA., O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA., DiPrimeo D; Biometrics, Puma Biotechnology Inc., Los Angeles, CA, USA., Eli LD; Translational Medicine and Biometrics, Puma Biotechnology Inc., Los Angeles, CA, USA., Gordan JD; Division of Hematology/Oncology, CSF GI Medical Oncology, San Francisco, CA, USA., Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.
Source: Liver cancer [Liver Cancer] 2024 Aug 08; Vol. 14 (1), pp. 58-67. Date of Electronic Publication: 2024 Aug 08 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40144471
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abou-Alfa+GK%22">Abou-Alfa GK</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.; Department of Medicine, Medical School, Trinity College Dublin University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Meyer+T%22">Meyer T</searchLink>; Department of Oncology, Royal Free Hospital, London, UK.; Department of Oncology, UCL Cancer Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Do+RKG%22">Do RKG</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Piha-Paul+SA%22">Piha-Paul SA</searchLink>; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Light+JS%22">Light JS</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sherrin+S%22">Sherrin S</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yaqubie+A%22">Yaqubie A</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22O'Neill+AC%22">O'Neill AC</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Harding+JJ%22">Harding JJ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Al-Rajabi+R%22">Al-Rajabi R</searchLink>; Department of Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Denlinger+CS%22">Denlinger CS</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cano+P%22">Cano P</searchLink>; Department of Hematology/Oncology, Sudbury Regional Hospital, Sudbury, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Cornelius+AS%22">Cornelius AS</searchLink>; Department of Medicine, Helen DeVos Children's Hospital, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22O'Reilly+EM%22">O'Reilly EM</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22DiPrimeo+D%22">DiPrimeo D</searchLink>; Biometrics, Puma Biotechnology Inc., Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Eli+LD%22">Eli LD</searchLink>; Translational Medicine and Biometrics, Puma Biotechnology Inc., Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gordan+JD%22">Gordan JD</searchLink>; Division of Hematology/Oncology, CSF GI Medical Oncology, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Solit+DB%22">Solit DB</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101597993%22">Liver cancer</searchLink> [Liver Cancer] 2024 Aug 08; Vol. 14 (1), pp. 58-67. <i>Date of Electronic Publication: </i>2024 Aug 08 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597993 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2235-1795 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216645553%22">16645553 </searchLink><i>NLM ISO Abbreviation: </i>Liver Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40144471
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000540290
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 58
    Titles:
      – TitleFull: Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abou-Alfa GK
      – PersonEntity:
          Name:
            NameFull: Meyer T
      – PersonEntity:
          Name:
            NameFull: Do RKG
      – PersonEntity:
          Name:
            NameFull: Piha-Paul SA
      – PersonEntity:
          Name:
            NameFull: Light JS
      – PersonEntity:
          Name:
            NameFull: Sherrin S
      – PersonEntity:
          Name:
            NameFull: Yaqubie A
      – PersonEntity:
          Name:
            NameFull: O'Neill AC
      – PersonEntity:
          Name:
            NameFull: Harding JJ
      – PersonEntity:
          Name:
            NameFull: Al-Rajabi R
      – PersonEntity:
          Name:
            NameFull: Denlinger CS
      – PersonEntity:
          Name:
            NameFull: Cano P
      – PersonEntity:
          Name:
            NameFull: Cornelius AS
      – PersonEntity:
          Name:
            NameFull: O'Reilly EM
      – PersonEntity:
          Name:
            NameFull: DiPrimeo D
      – PersonEntity:
          Name:
            NameFull: Eli LD
      – PersonEntity:
          Name:
            NameFull: Gordan JD
      – PersonEntity:
          Name:
            NameFull: Solit DB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 08
              Text: 2024 Aug 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2235-1795
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Liver cancer
              Type: main
ResultId 1